Caribou Biosciences

Caribou Biosciences CRBU Stock

$0.28   -8.438000%
Add to favorites
Market Cap
$30.71M
LOW - HIGH [24H]
$0.28 - $0.30
VOLUME [24H]
$3.26M
P/E Ratio
0
Earnings per share
-$1.03
ISIN
US1420381089
Price   Prediction

Caribou Biosciences Price Chart

Sorry, that's all we've gotfor now...

Caribou Biosciences (CRBU) stock price today is 0.28 USD on Tech Market Large (-8.44% on the day). Updated .

Caribou Biosciences CRBU Financial and Trading Overview

Caribou Biosciences stock price 0.28 USD
Previous Close 0.31 USD
Open 0.3 USD
Bid 0.29 USD x 100
Ask 0.31 USD x 100
Day's Range 0.28 - 0.31 USD
52 Week Range 0.28 - 2.49 USD
Volume 3.26M USD
Avg. Volume 2.84M USD
Market Cap 30.71M USD
Beta (5Y Monthly) 2.488
PE Ratio (TTM) N/A
EPS (TTM) -1.03 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 5 USD

CRBU Valuation Measures

Enterprise Value -37747156 USD
Trailing P/E N/A
Forward P/E -0.43963692
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 3.252313
Price/Book (mrq) 0.4009873
Enterprise Value/Revenue -3.997
Enterprise Value/EBITDA 0.359

Trading Information

Caribou Biosciences Stock Price History

Beta (5Y Monthly) 2.488
52-Week Change -82.22%
S&P500 52-Week Change 8.67%
52 Week High 2.49 USD
52 Week Low 0.28 USD
50-Day Moving Average 0.74 USD
200-Day Moving Average 1.55 USD

CRBU Share Statistics

Avg. Volume (3 month) 2.84M USD
Avg. Daily Volume (10-Days) 2.27M USD
Shares Outstanding 108.04M
Float 103.74M
Short Ratio 2.84
% Held by Insiders 8.07%
% Held by Institutions 49.31%
Shares Short 14.89M
Short % of Float 14.31%
Short % of Shares Outstanding 13.78%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) -1140.55%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -42.33%
Return on Equity (ttm) -93.80%

Income Statement

Revenue (ttm) 9.44M USD
Revenue Per Share (ttm) 0.1 USD
Quarterly Revenue Growth (yoy) -26.90%
Gross Profit (ttm) -75273000 USD
EBITDA -105168000 USD
Net Income Avi to Common (ttm) -102467000 USD
Diluted EPS (ttm) -0.94
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 94.8M USD
Total Cash Per Share (mrq) 0.88 USD
Total Debt (mrq) 26.34M USD
Total Debt/Equity (mrq) 34.37 USD
Current Ratio (mrq) 4.968
Book Value Per Share (mrq) 0.709

Cash Flow Statement

Operating Cash Flow (ttm) -93113000 USD
Levered Free Cash Flow (ttm) -58627248 USD

Profile of Caribou Biosciences

Country United States
State CA
City Berkeley
Address 2929 7th Street
ZIP 94710
Phone 510 982 6030
Website https://cariboubio.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 97

Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.

Q&A For Caribou Biosciences Stock

What is a current CRBU stock price?

Caribou Biosciences CRBU stock price today per share is 0.28 USD.

How to purchase Caribou Biosciences stock?

You can buy CRBU shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Caribou Biosciences?

The stock symbol or ticker of Caribou Biosciences is CRBU.

Which industry does the Caribou Biosciences company belong to?

The Caribou Biosciences industry is Biotechnology.

How many shares does Caribou Biosciences have in circulation?

The max supply of Caribou Biosciences shares is 108.04M.

What is Caribou Biosciences Price to Earnings Ratio (PE Ratio)?

Caribou Biosciences PE Ratio is now.

What was Caribou Biosciences earnings per share over the trailing 12 months (TTM)?

Caribou Biosciences EPS is -1.03 USD over the trailing 12 months.

Which sector does the Caribou Biosciences company belong to?

The Caribou Biosciences sector is Healthcare.

Caribou Biosciences CRBU included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 22617.73 USD —
-5.28
10.6B USD — 22513.01 USD — 23837.76 USD — — 10.6B USD —
us US Tech Health Care IXHC US 1282.67 USD —
-1.79
— — 1279.99 USD — 1317.94 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
us US Tech Global Select Market Com NQGS US 11139.01 USD —
-5.31
— — 11086.73 USD — 11742.47 USD — — — —
us US Tech Biotechnology NBI US 6781.89 USD —
-1.73
— — 6767.31 USD — 6980.47 USD — — — —
$2.07T
Total marketcap
$106.64B
Total volume
BTC 57.78%   •   ETH 9.86%
Dominance
Select currency